Expansion of US Sales Force at Visioneering Technologies, Inc.

HRS Scientific Sessions: Boston Scientific LBCT

During the Heart Rhythm Scientific Sessions this week, Boston Scientific announced positive LBCT data underscoring the safety and efficacy of multi-site pacing (MSP) over conventional cardiac resynchronization therapy (CRT), as well as poster presentations on real-world use of the WATCHMAN Left Atrial Appendage Closure (LAAC) device and next-generation WATCHMAN FLX LAAC device as alternatives to oral anticoagulation therapy for stroke risk reduction in patients with non-valvular atrial fibrillation.

What are the Most Commonly Performed Surgeries?

Whether you are trying to learn more about a surgery you are planning to have or find out what the most common procedures are, this list is here for you. Read more.

B2B Training: What’s the Most Effective Way of Learning?

B2B training, which is short for business-to-business training, is a popular and convenient type of training that enables entire companies to train their teams...


Mr. Joshua Suarez: District Sales Manager for the western United States

Visioneering Technologies, Inc. (ASX: VTI), a US-based medical device company (‘Visioneering’ or ‘The Company’) engaged in the design, manufacture, sale and distribution of its proprietary NaturalVue® Multifocal 1 Day Contact Lenses, is pleased to announce the recent expansion of its US sales force.

Mr. Joshua Suarez as new District Sales Manager for the western United States: Mr. Suarez has over 14 years’ experience in senior sales roles in the healthcare and medtech industries in the US.  Most recently, Joshua was the Regional Business Manager at Voyce (i4C Innovations Inc.) where he built a new region and led sales and training for the start-up remote monitoring device company. Prior to this, he was the Senior Area Business Manager at Zoetis Inc.

The company advises that ten new sales representatives have been added across the country.

Visioneering’s Senior Vice President of Sales & Marketing, Tony Sommer stated he was delighted with the seniority and depth of experience their new hires bring to VTI. “I am confident that Joshua’s leadership skills and extensive experience will enrich VTI as we focus on building strong and long term partnerships with the eye-care industry.”

Mr. Sommer continued “There is significant interest building around the NaturalVue Multifocal. Our recent successful finance raise is enabling us to increase our sales coverage and strengthen our commercialization efforts across the country.”

These new, highly-experienced sales representatives will cover Northern and Southern California (Los Angeles, San Diego, Sacramento and San Francisco), the northeast (including New York City, Long Island, upstate New York, Connecticut and New Jersey), Ohio (Cincinnati) and the Carolinas.

CEO and Executive Director Dr. Stephen Snowdy said, “We plan to build out our US sales force to 45 sales representatives over the next 12 months, and we are off to a running start with the addition of 11 new sales personnel.”



Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.